31OT cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharyngeal carcinoma. (17th December 2018) - Pedrazzoli, P; Comoli, P; Secondino, S; Gurrado, A; Pagani, A; Zecca, M